Archived News for Health Sector Professionals - May, 2022
Lab milk release looms
Eden Brew - a company making milk in a lab - is raising millions in new capital.
Tobacco harms tallied
The WHO has published new stats on the damage tobacco causes to both the environment and human health.
Health tech spend for Tas.
Tasmania has announced a major investment in digital health, aimed at improving patient care.
IVF subsidies coming
NSW is planning to offer rebates to people undergoing fertility treatment at private clinics.
Peanut genes probed
Australian researchers have discovered new details behind peanut allergy remission in children.
COVID stress could flow to foetus
A small study suggests pandemic distress may affect foetal brain development.
Millions flow to medical quests
University of Sydney researchers have secured over $12 million in clinical trial funding.
Pfizer to provide cheap treatments
Pfizer says it will begin providing treatments at not-for-profit prices in some of the world’s poorest countries.
Eye protection observed
Researchers have made the world-first discovery of cornea T cells protecting eyes from viral infections.
VR tested in aged care
A new study suggests virtual reality has the power to transform the day-to-day lives of aged care residents.
WEHI team drives drug boost
Australian experts are pushing to reduce the high failure rates in drug discovery and development.
Long COVID clinics grow
South Australia is creating new clinics to deal with the legacy of ‘long COVID’.
NSW approves VAD scheme
New South Wales has become Australia’s last state to legalise voluntary assisted dying.
Special staff aid WA ambulance
Firefighters, police and government officials are being sent to help St John WA.
WHO meets on monkeypox
The World Health Organization (WHO) has held an emergency meeting on recent monkeypox outbreaks.
Folbigg review secured
Australian academics have successfully pushed for the review of a historic murder case.
Life flickers in donated eyes
Scientists have briefly revived light-sensing cells in the eyes of a deceased person.
Antibody slide studied
A new study has looked at the decline of antibodies following infection with the COVID Omicron strain.